159 related articles for article (PubMed ID: 15780820)
1. The role of the adipocyte hormone adiponectin in cardiovascular disease.
Hug C; Lodish HF
Curr Opin Pharmacol; 2005 Apr; 5(2):129-34. PubMed ID: 15780820
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome.
Trujillo ME; Scherer PE
J Intern Med; 2005 Feb; 257(2):167-75. PubMed ID: 15656875
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin, obesity, and cardiovascular disease.
Fasshauer M; Paschke R; Stumvoll M
Biochimie; 2004 Nov; 86(11):779-84. PubMed ID: 15589686
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and atherosclerotic disease.
Shimada K; Miyazaki T; Daida H
Clin Chim Acta; 2004 Jun; 344(1-2):1-12. PubMed ID: 15149866
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
Lara-Castro C; Fu Y; Chung BH; Garvey WT
Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
[TBL] [Abstract][Full Text] [Related]
6. AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome.
McCarty MF
Med Hypotheses; 2005; 64(6):1211-5. PubMed ID: 15823720
[TBL] [Abstract][Full Text] [Related]
7. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin and cardiovascular disease: response to therapeutic interventions.
Han SH; Quon MJ; Kim JA; Koh KK
J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
[TBL] [Abstract][Full Text] [Related]
9. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis.
Staiger H; Häring HU
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):67-79. PubMed ID: 15772897
[TBL] [Abstract][Full Text] [Related]
10. Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.
Huypens P; Quartier E; Pipeleers D; Van de Casteele M
Eur J Pharmacol; 2005 Aug; 518(2-3):90-5. PubMed ID: 16039647
[TBL] [Abstract][Full Text] [Related]
11. White adipose tissue and cardiovascular disease.
Matsuzawa Y
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):637-47. PubMed ID: 16311222
[TBL] [Abstract][Full Text] [Related]
12. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
13. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue as an endocrine organ.
Ahima RS
Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():242S-249S. PubMed ID: 17021375
[TBL] [Abstract][Full Text] [Related]
15. Cloning and expression of adiponectin and its globular domain, and measurement of the biological activity in vivo.
Hu XB; Zhang YJ; Zhang HT; Yang SL; Gong Y
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):1023-8. PubMed ID: 14614541
[TBL] [Abstract][Full Text] [Related]
16. Assessing risk across the spectrum of patients with the metabolic syndrome.
Rosenson RS
Am J Cardiol; 2005 Aug; 96(4A):8E-10E. PubMed ID: 16098836
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular actions of adiponectin: pathophysiologic implications.
Maia-Fernandes T; Roncon-Albuquerque R; Leite-Moreira AF
Rev Port Cardiol; 2008 Nov; 27(11):1431-49. PubMed ID: 19227810
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin and chronic kidney disease.
Guebre-Egziabher F; Drai J; Fouque D
J Ren Nutr; 2007 Jan; 17(1):9-12. PubMed ID: 17198925
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin--a key adipokine in the metabolic syndrome.
Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
[TBL] [Abstract][Full Text] [Related]
20. Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk.
Schöndorf T; Maiworm A; Emmison N; Forst T; Pfützner A
Clin Lab; 2005; 51(9-10):489-94. PubMed ID: 16285470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
